Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphaëlle Delattre

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biomedicines|February 24, 2024
High-Throughput Bacteriophage Testing with Potency Determination: Validation of an Automated Pipetting and Phage Drop-Off MethodNicolas Dufour, Raphaëlle Delattre, Laurent Debarbieux
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
In Vivo Bacteriophage BiodistributionNicolas Dufour, Raphaëlle Delattre, Laurent Debarbieux
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-LactamsNicolas Dufour, Raphaëlle Delattre, Jean-Damien Ricard, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in MiceNicolas Dufour, Raphaëlle Delattre, Anne Chevallereau, et al.
Journal of Virology|August 30, 2024
Variable fitness effects of bacteriophage resistance mutations in <i>Escherichia coli:</i> implications for phage therapyBaptiste Gaborieau, Raphaëlle Delattre, Sandrine Adiba, et al.
ISME Communications|September 19, 2024
A nanoluciferase-encoded bacteriophage illuminates viral infection dynamics of <i>Pseudomonas aeruginosa</i> cellsSophia Zborowsky, Quentin Balacheff, Ioanna Theodorou, et al.
Cell Reports|May 18, 2022
Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacyRaphaëlle Delattre, Jérémy Seurat, Feyrouz Haddad, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biomedicines|February 24, 2024
High-Throughput Bacteriophage Testing with Potency Determination: Validation of an Automated Pipetting and Phage Drop-Off MethodNicolas Dufour, Raphaëlle Delattre, Laurent Debarbieux
Methods in Molecular Biology (Clifton, N.J.)|November 10, 2017
In Vivo Bacteriophage BiodistributionNicolas Dufour, Raphaëlle Delattre, Laurent Debarbieux
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 23, 2017
The Lysis of Pathogenic Escherichia coli by Bacteriophages Releases Less Endotoxin Than by β-LactamsNicolas Dufour, Raphaëlle Delattre, Jean-Damien Ricard, et al.
Antimicrobial Agents and Chemotherapy|June 12, 2019
Phage Therapy of Pneumonia Is Not Associated with an Overstimulation of the Inflammatory Response Compared to Antibiotic Treatment in MiceNicolas Dufour, Raphaëlle Delattre, Anne Chevallereau, et al.
Journal of Virology|August 30, 2024
Variable fitness effects of bacteriophage resistance mutations in <i>Escherichia coli:</i> implications for phage therapyBaptiste Gaborieau, Raphaëlle Delattre, Sandrine Adiba, et al.
ISME Communications|September 19, 2024
A nanoluciferase-encoded bacteriophage illuminates viral infection dynamics of <i>Pseudomonas aeruginosa</i> cellsSophia Zborowsky, Quentin Balacheff, Ioanna Theodorou, et al.
Cell Reports|May 18, 2022
Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacyRaphaëlle Delattre, Jérémy Seurat, Feyrouz Haddad, et al.
Pageof 1